Skip to main content

EuroDry Ltd. Reports Results for the Quarter and Year Ended December 31, 2025

ATHENS, Greece, Feb. 19, 2026 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today its results for the three and twelve-month periods ended December 31, 2025.   Fourth Quarter 2025 Highlights:Total net revenues of $17.4 million.Net income attributable to controlling shareholders, of $3.2 million or $1.14 earnings per share attributable to controlling shareholders basic and diluted.Adjusted net income1 attributable to controlling shareholders, for the quarter of $2.4 million, or, $0.88 and $0.87 per share attributable to controlling shareholders basic and diluted, respectively, which excludes among other items the net gain on sale of one of our vessels of $0.7 million.Adjusted EBITDA1...

Continue reading

Employers Holdings, Inc. Reports Fourth Quarter 2025 and Full-Year Financial Results; Declares Quarterly Cash Dividend of $0.32 per Share; and Announces Completion of $125 million Recapitalization Plan

Company to Host Conference Call on Friday, February 20, 2026, at 11:00 a.m. Eastern Standard Time RENO, Nev., Feb. 19, 2026 (GLOBE NEWSWIRE) — Employers Holdings, Inc. (the “Company”) (NYSE:EIG), a holding company with subsidiaries that are specialty providers of workers’ compensation insurance, excess workers’ compensation, and related services, today reported financial results for its full year and fourth quarter ended December 31, 2025. Full-Year 2025 Financial Highlights(All comparisons versus full-year 2024)Net income of $10.8 million ($0.46 per diluted share), versus $118.6 million ($4.71 per diluted share); Adjusted net income of $21.8 million ($0.93 per diluted share), versus $94.0 million ($3.73 per diluted share); Gross premiums written of $756.1 million, versus $776.3 million; Net premiums earned of $761.9 million,...

Continue reading

Vicor Corporation Reports Results for the Fourth Quarter and Year Ended December 31, 2025

ANDOVER, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: VICR) today reported financial results for the fourth quarter and year ended December 31, 2025. These results will be discussed later today at 5:00 p.m. Eastern Time, during management’s quarterly investor conference call. The details for the call are below. Product revenue for the fourth quarter ended December 31, 2025 totaled $92.7 million, a 15.3% increase from $80.4 million for the corresponding period a year ago, and a 4.5% sequential increase from $88.7 million in the third quarter of 2025. Royalty revenue for the fourth quarter ended December 31, 2025 totaled $14.5 million, a 7.8% decrease from $15.8 million for the corresponding period a year ago, and a 33.1% sequential decrease from $21.7 million in the third quarter of 2025. The sequential decrease...

Continue reading

Altus Group Reports Q4 & Fiscal 2025 Financial Results & Quarterly Dividend

Increases 2026 capital return objectives to up to $800 million and renews normal course issuer bid TORONTO, Feb. 19, 2026 (GLOBE NEWSWIRE) — Altus Group Limited (ʺAltus Group” or “the Company”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, announced today its financial and operating results for the fourth quarter and year ended December 31, 2025. The Company also announced that its Board of Directors (“Board”) approved the payment of a cash dividend of $0.15 per common share for the first quarter ending March 31, 2026, as well as an increase to the Company’s annual capital return objectives to up to $800 million. As further described below, the Toronto Stock Exchange (“TSX”) has approved the Company’s notice of intention to renew its normal course issuer bid (“NCIB”), and the Company is evaluating...

Continue reading

Texas Roadhouse, Inc. Announces Fourth Quarter 2025 Results

Increases Quarterly Dividend to $0.75 per Share LOUISVILLE, K.Y., Feb. 19, 2026 (GLOBE NEWSWIRE) — Texas Roadhouse, Inc. (NasdaqGS: TXRH), today announced financial results for the fourth quarter and fiscal year ended December 30, 2025. Financial Results Financial results for the fourth quarter and fiscal year ended December 30, 2025 and December 31, 2024 were as follows:    Fourth Quarter Ended   Fiscal Year Ended($000’s, except per share amounts)   December 30, 2025   December 31, 2024   % change   December 30, 2025   December 31, 2024   % changeTotal revenue   $ 1,482,031   $ 1,437,914   3.1 %   $ 5,878,075   $ 5,373,332   9.4 %Income from operations     96,717     138,552   (30.2 %)     474,740     516,519   (8.1 %)Net income     84,635     115,833   (26.9 %)     405,554     433,592   (6.5 %)Diluted...

Continue reading

Spyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

On track for 6 proof-of-concept readouts in 2026 across the SKYLINE and SKYWAY Phase 2 trials  Part A readouts from SKYLINE platform trial in ulcerative colitis (“UC”) expected to begin in the second quarter, with enrollment continuing ahead of schedule Enrollment on track in Phase 2 SKYWAY basket trial evaluating TL1A inhibition in rheumatoid arthritis (“RA”), psoriatic arthritis (“PsA”), and axial spondyloarthritis (“axSpA”), with fourth quarter readouts expected in each sub-study Strengthened the balance sheet with an underwritten public offering of common stock in October 2025 and announced the appointment of Kate Tansey Chevlen as Chief Commercial Officer (CCO) $757 million of cash, cash equivalents, and marketable securities as of December 31, 2025, with expected runway into the second...

Continue reading

Ardelyx Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

IBSRELA revenue grew 73% in 2025 to $274.2 million and total revenues reached $407.3 million Patient-first XPHOZAH strategy preserved access and drove growth in total dispenses Development programs for new IBSRELA indication and next-generation NHE3 inhibitor launched Company is well capitalized to meet current business objectives Conference call scheduled for 4:30 PM Eastern Time WALTHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update. “The results we delivered in 2025 reflect our team’s hard work and disciplined execution...

Continue reading

Federal Home Loan Bank of Indianapolis Announces Fourth Quarter 2025 Dividends, Reports Earnings

INDIANAPOLIS, Feb. 19, 2026 (GLOBE NEWSWIRE) — Today the Board of Directors of the Federal Home Loan Bank of Indianapolis (“FHLBank Indianapolis” or “Bank”) declared its fourth quarter 2025 dividends on Class B-2 activity-based capital stock and Class B-1 non-activity-based stock at annualized rates of 9.50% and 4.00%, respectively. The dividends will be paid in cash on February 20, 2026. Earnings Highlights Three Months Ended December 31, 2025 Net interest income was $131 million, a net increase of $8 million compared to the corresponding period in the prior year. The increase was primarily due to higher interest spreads on interest-earning assets, net of interest-bearing liabilities, partially offset by lower earnings generated from investing our capital in interest-earning assets. Net income was $73 million,...

Continue reading

GTT : Full Year 2025 Results – Strong growth in revenues (+25%) and EBITDA (+40%) for the third consecutive year.

FY 2025 resultsStrong growth in revenues (+25%) and EBITDA (+40%) for the third consecutive year.Strong upturn in vessel orders since the fourth quarter of 2025.2025 dividend at a record level of €8.94 per share. Paris, February 19, 2026. GTT, the technological expert in membrane containment systems used to transport and store liquefied gases, today announces its results for the 2025 financial year. Key figures for the 2025 financial year  2024 2025 2025/2024Consolidated revenues €641 M €803 M +25%Consolidated EBITDA €388 M €542 M +40%Proposed dividend €7.50per share €8.94per share +19%Highlights45 orders received during the financial year, including 37 orders for LNG carriers, of which 18 in the fourth quarterOrder book with 288 units for the core business and 48 units for the LNG as fuel businessRecord number...

Continue reading

Coface closes another strong year with 2025 net income at €222.0m, solvency at 197% and an 84% distribution for a proposed dividend of €1.25 per share

Coface closes another strong year with 2025 net income at €222.0m, solvency at 197% and an 84% distribution for a proposed dividend of €1.25 per share Paris, 19 February 2026 – 17.35Turnover: €1,847m, up +1.3% at constant FX and perimeterInsurance revenue is up +0.6% at constant FX, while customer activity is up +2.6% Client retention remains at a high level (+92.9%), while pricing remains negative at -1.6%, in line with historical trends Non-insurance activities (factoring, information services and debt collection) grow by +7.8% to €166.2m. The double-digit growth in information services continues (+16.2% at constant FX and +18.8% including Cedar Rose). Debt collection is up +24.4% and factoring is down slightly, by -2.7%Net loss ratio at 40.3%, up 5.1 ppts; net combined ratio at 73.1%, up 7.6 pptsGross loss ratio at 37.5%,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.